About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Molecular Markers of Prognosis in Colorectal Cancer Patients

NCT00220142·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Royal Marsden NHS Foundation Trust

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

All patients participating in the RMHNHST study of infusional versus bolus 5FU (Saini et al. 2003).

The record

StatusCompleted

PhaseNo phase

Taking part103

StartedNov 2003

UpdatedMay 31, 2013

Conditions

Colorectal Cancer

Where1

Royal Marsden Hospital
Sutton, Surrey, United Kingdom

Clareo Health | Molecular Markers of Prognosis in Colorectal Cancer Patients